Old Web
English
Sign In
Acemap
>
authorDetail
>
Nate H. Wallace
Nate H. Wallace
Cephalon
Immunology
Lupus nephritis
Biology
Lupus erythematosus
Proinflammatory cytokine
4
Papers
128
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer
2012
Molecular Cancer Therapeutics
Matthew Seavey
Lily D. Lu
Kristine L. Stump
Nate H. Wallace
William Hockeimer
Teresa M. OKane
Bruce Ruggeri
Pawel Dobrzanski
Show All
Source
Cite
Save
Citations (30)
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE.
2012
International Immunopharmacology
Matthew M. Seavey
Lily D. Lu
Kristine L. Stump
Nate H. Wallace
Bruce Ruggeri
Show All
Source
Cite
Save
Citations (45)
Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2
2011
Journal of Immunology
Lily D. Lu
Kristine L. Stump
Nate H. Wallace
Pawel Dobrzanski
Cynthia Serdikoff
Diane E. Gingrich
Benjamin J. Dugan
Thelma S. Angeles
Mark S. Albom
Jennifer L. Mason
Mark A. Ator
Bruce D. Dorsey
Bruce Ruggeri
Matthew M. Seavey
Show All
Source
Cite
Save
Citations (53)
Novel, orally active proteasome inhibitor, CEP-18770, protects and treats disease in preclinical mouse models of lupus nephritis
2011
Journal of Immunology
Matthew Seavey
Lily D. Lu
Kristine L. Stump
Nate H. Wallace
Bruce Ruggeri
Show All
Source
Cite
Save
Citations (0)
1